AERIE PHARMACEUTICALS INC - COM (AERI)

Historical Institutional Holders from Q1 2014 to Q4 2022

All holders as of December 31, 2022
Q4 2022
Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2022 Q4 0 $0 -$673M 0
2022 Q3 46.9M $710M +$45.7M $15.13 149
2022 Q2 47.1M $354M -$6.57M $7.50 130
2022 Q1 48M $437M +$14.7M $9.10 131
2021 Q4 47.3M $332M -$7.11M $7.02 127
2021 Q3 46.3M $528M -$10.2M $11.40 135
2021 Q2 45.7M $732M -$7.84M $16.01 140
2021 Q1 46.1M $823M +$42.5M $17.87 157
2020 Q4 44.6M $602M -$27.8M $13.51 146
2020 Q3 46.9M $552M -$22.2M $11.77 146
2020 Q2 48.4M $712M -$58.5M $14.76 154
2020 Q1 52M $700M -$98.9M $13.50 148
2019 Q4 57.7M $1.39B +$38.8M $24.17 165
2019 Q3 56.7M $1.09B +$114M $19.22 165
2019 Q2 48.4M $1.43B -$10.5M $29.55 159
2019 Q1 47.4M $2.25B -$50.4M $47.50 168
2018 Q4 49.4M $1.78B -$13.3M $36.10 157
2018 Q3 47.9M $2.95B +$260M $61.55 175
2018 Q2 43.7M $2.95B +$53.7M $67.55 176
2018 Q1 42.9M $2.33B +$250M $54.25 169
2017 Q4 38.3M $2.29B +$20.5M $59.75 173
2017 Q3 37.6M $1.83B +$150M $48.60 179
2017 Q2 34.5M $1.81B +$118M $52.55 175
2017 Q1 32.4M $1.47B +$64.8M $45.35 158
2016 Q4 33.8M $1.28B +$46.5M $37.85 150
2016 Q3 32.4M $1.22B +$176M $37.74 161
2016 Q2 27.8M $489M +$19.4M $17.60 103
2016 Q1 26.2M $319M +$5.36M $12.16 97
2015 Q4 24.6M $596M -$6.24M $24.35 113
2015 Q3 24.6M $437M +$18.3M $17.74 113
2015 Q2 23.6M $416M -$31.3M $17.65 105
2015 Q1 22.1M $693M +$30.5M $31.34 122
2014 Q4 21.2M $619M +$48.9M $29.19 96
2014 Q3 19.5M $404M +$77.4M $20.69 75
2014 Q2 12.2M $302M +$44.7M $24.77 58
2014 Q1 10.6M $225M +$4.6M $21.19 52